Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2014
03/20/2014WO2014043084A1 Polymer-polymer composite nanoassemblies and applications thereof
03/20/2014WO2014042945A1 Methods for making pharmaceutical solid dosage forms of spray-dried dispersions
03/20/2014WO2014042921A1 Composite hydrogels for delivery of biologically active materials
03/20/2014WO2014042790A1 Antimicrobial alcoholic foamable compositions
03/20/2014WO2014042604A1 Clindamycin phosphate, salicylic acid and tea tree oil combinations
03/20/2014WO2014042416A1 Oral composition containing dapoxetin-free base
03/20/2014WO2014042250A1 Drug-containing ultrafine fiber and utilization thereof
03/20/2014WO2014042142A1 Surface-modified iron oxide particles for cancer cauterization
03/20/2014WO2014041563A1 Synergistic anti-cancer composition and a process for the preparation thereof
03/20/2014WO2014041551A1 Formulation comprising imatinib as oral solution
03/20/2014WO2014041543A1 Improved wound healing compositions comprising microspheres
03/20/2014WO2014041489A2 Pharmaceutical dosage form
03/20/2014WO2014041485A1 Fast dissolving ocular insert
03/20/2014WO2014041425A1 Daptomycin formulations and uses thereof
03/20/2014WO2014041378A2 Topical pharmaceutical composition
03/20/2014WO2014041231A1 Hydrogel used as an injectable support for application in cell therapy and as a system for the controlled release of drugs
03/20/2014WO2014041142A1 Tablet formulation of a phosphatidylinositol 3-kinase inhibitor
03/20/2014WO2014041120A1 Multipurpose drug delivery systems for long-term implantation or insertion
03/20/2014WO2014041071A1 Semifluorinated alkane compositions
03/20/2014WO2014041015A1 Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it.
03/20/2014WO2014041001A1 Alternative method for microencapsulation of active ingredients
03/20/2014WO2014040994A1 Compositions comprising peg and ascorbate
03/20/2014WO2014040921A1 A pharmaceutical composition
03/20/2014WO2014040577A1 A stable pharmaceutical formulation containing vardenafil hydrochloride
03/20/2014WO2014040548A1 Metoprolol sustained-release drug and preparation method therefor
03/20/2014WO2014040239A1 Cefuroxime sodium crystal compound and composition powder injection thereof
03/20/2014WO2014018932A3 Effluz inhibitor compositions and methods of treatment using the same
03/20/2014WO2014017845A3 A liquid formulation of long acting insulinotropic peptide conjugate
03/20/2014WO2014009682A3 Improved apparatus and method for mineralising biological material
03/20/2014WO2014007772A3 Inhalation compositions comprising glucose anhydrous
03/20/2014WO2014007770A3 Inhalation compositions comprising corticosteroid and sorbitol
03/20/2014WO2014006601A3 Nanoparticle compositions of antibacterial compounds and other uses thereof
03/20/2014WO2014006571A3 Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof
03/20/2014WO2014006261A3 Microparticles for the encapsulation of probiotics, preparation and uses thereof
03/20/2014WO2013174752A3 System composed of inhaler and capsule
03/20/2014WO2013109202A3 Pharmaceutical compounds comprising cefetamet
03/20/2014WO2013087405A3 Release capsules, manufacture and uses thereof
03/20/2014WO2012009438A3 Anti-appetite adhesive compositions
03/20/2014US20140081223 Medicated Patch
03/20/2014US20140081070 Biodegradable Multilayer Constructs
03/20/2014US20140080915 Abuse-proofed dosage forms
03/20/2014US20140080906 Fat emulsion providing taste masking for active health and wellness ingredients
03/20/2014US20140080880 Bendamustine Formulations
03/20/2014US20140080864 Pharmacetuical composition comprising drotaverine
03/20/2014US20140080858 Abuse-proofed dosage forms
03/20/2014US20140080857 Methods for prophylatic appetite suppression
03/20/2014US20140080836 Methods and compositions for treating or preventing erythema
03/20/2014US20140080812 Novel parenteral carbamazepine formulation
03/20/2014US20140080778 Use of secnidazole in treatment of dental infections
03/20/2014US20140080771 Method for treating rhinitis and sinusitis by rhamnolipids
03/20/2014US20140079816 Cross-linked biopolymers, related compositions and methods of use
03/20/2014US20140079804 Compositions and methods for treatment of infections
03/20/2014US20140079795 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
03/20/2014US20140079792 Coating composition suitable for pharmaceutical or nutraceutical dosage forms
03/20/2014US20140079790 Multi-encapsulated formulations made with oxidized cellulose for in-situ reactions
03/20/2014US20140079787 Methods for treating hepatocellular carcinoma
03/20/2014US20140079782 Particulate materials
03/20/2014US20140079781 Pharmaceutical compositions
03/20/2014US20140079780 Crush resistant delayed-release dosage forms
03/20/2014US20140079779 Modified Release Tranexamic Acid Formulation
03/20/2014US20140079778 Pharmaceutical Formulations Including An Amine Compound
03/20/2014US20140079777 Dry powder vancomycin compositions and associated methods
03/20/2014US20140079776 Nanostructures for Drug Delivery
03/20/2014US20140079774 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/20/2014US20140079773 Encapsulating liposomes
03/20/2014US20140079770 Vector for pulmonary delivery, inducing agent, and uses
03/20/2014US20140079768 Compositions and methods for treatment of osteoporosis and other indications
03/20/2014US20140079767 Cancer treatments and compositions for use thereof
03/20/2014US20140079766 Methods and compositions for muscular and neuromuscular diseases
03/20/2014US20140079765 Techniques and systems for treatment of neuropathic pain and other indications
03/20/2014US20140079764 Treatment and prevention of learning and memory disorders
03/20/2014US20140079762 Treatment of skin and soft tissue infection with nitric oxide
03/20/2014US20140079761 Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
03/20/2014US20140079759 Fibrous polymer scaffolds having diametrically patterned polymer fibers
03/20/2014US20140079758 Electrospun material covered medical appliances and methods of manufacture
03/20/2014US20140079757 Oral drug delivery formulations
03/20/2014US20140079756 Compressed Chewing Gum Tablet
03/20/2014US20140079754 Microfabricated nanopore device for sustained release of therapeutic agent
03/20/2014US20140079752 Injectable, Pore-Forming Hydrogels for Materials-Based Cell Therapies
03/20/2014US20140079746 Fullerenes and other cage molecular structures in a special hydrated state
03/20/2014US20140079741 Inhibition and treatment of biofilms
03/20/2014US20140079740 Oral transmucosal adminstration forms of s-ketamine
03/20/2014US20140079694 Cai-based systems and methods for the localized treatment of ocular and other diseases
03/20/2014US20140079648 Antimicrobial alcoholic foamable compositions
03/20/2014US20140079647 Cefdinir and cefixime formulations and uses thereof
03/20/2014US20140079646 Pharmaceutical formulation for treating the upper digestive tract
03/20/2014US20140079644 Cellulose-based nanoparticles for drug delivery
03/20/2014US20140079642 Nanoparticles based for dermal and systemic delivery of drugs
03/20/2014US20140076763 Peelable Pouch for Transdermal Patch and Method for Packaging
03/20/2014DE112011105169T5 Neue pharmazeutische Zusammensetzung mit geringen Nebenwirkungen enthaltend anti-Tuberkulose Arzneimittel New pharmaceutical composition with minimal side effects including anti-tuberculosis drugs
03/19/2014EP2708570A1 Gelatin Particle and Use Thereof, and Device for Administration of Physiologically Active Substance
03/19/2014EP2708264A2 Cosmetic two component preparation
03/19/2014EP2708229A1 Non-aqueous patch
03/19/2014EP2708227A1 Multi-Encapsulated Formulations Made With Oxidized Cellulose For In-Situ Reactions
03/19/2014EP2708226A1 Multi-Encapsulated Formulations Made With Oxidized Cellulose
03/19/2014EP2708225A1 DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
03/19/2014EP2708224A1 Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
03/19/2014EP2708213A1 Multipurpose ethylene vinyl acetate fibrous drug delivery systems for long-term implantation or insertion
03/19/2014EP2707419A2 Reversibly crosslinked micelle systems
03/19/2014EP2707129A1 Edible liquid filled polysaccharide capsules
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 2991